(JTA) — The genetic testing company 23andMe is facing a class action lawsuit over its security practices after hackers stole and published data about 1 million people with Jewish ancestry.

Genetic testing specialist 23andMe has launched a strategic review that could result in a sale of the company, after months of speculation about its future. The company's board has formed a ...

The genetic testing company 23andMe has agreed to pay $30 million to American plaintiffs to settle a lawsuit over a data breach last year that specifically targeted customers of Ashkenazi Jewish ...

When evaluating 23andMe's stock performance and future outlook, investors should consider short-term market trends and long-term growth potential. This analysis will dive into recent stock metrics ...

23andMe's big push into drug development, announced with great fanfare almost a decade ago, has ended with a whimper and sweeping job losses. The company that made its name by providing saliva ...

Morning. Today, we talk about the likely confirmation of FDA nominee Marty Makary, go in-depth on NIH nominee Jay Bhattacharya, and see how much 23andMe CEO Anne Wojcicki is willing to pay for her ...

The group's genome-wide association study of 130,153 U.S.-based 23andMe research participants was compared with a similar UK Biobank database of 334,649 U.K. residents. The comparison revealed ...

Anna Wojcicki, the CEO of DNA testing app 23andMe that was sold for $6billion, is trying to buy the company back for just $75million. The troubled company was worth billions six years ago but now ...

Anne Wojcicki is at it again. After a failed attempt to buy back the DNA testing company she cofounded, the CEO has made another offer to gain control of 23andMe. But if the sale goes through ...

GWAS refers to genome-wide association study ... from an analysis of around one million people in collaboration with 23andMe which is a US-based genomics and biotechnology company.

23andMe Holding Co. is a consumer genetics and research company, which engages in assisting people to access, understand, and benefit from the human genome. It operates through the Consumer and ...

Genome-wide association studies (GWAS) help scientists understand the inheritance patterns of disorders on a global scale. But can we make predictions from these studies? Only a few years ago ...